Profile	GDS3514 / 207001_x_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	322.634	49
GSM325241	Patient no. 1: treated	262.834	45
GSM325242	Patient no. 9: control	1110.8	77
GSM325243	Patient no. 9: treated	613.392	65
GSM325244	Patient no. 18: control	327.179	45
GSM325245	Patient no. 18: treated	166.015	30
GSM325246	Patient no. 12: control	33.1889	15
GSM325247	Patient no. 12: treated	108.931	32
GSM325248	Patient no. 3: control	1918.01	84
GSM325249	Patient no. 3: treated	1173.63	75
GSM325250	Patient no. 7: control	223.008	45
GSM325251	Patient no. 7: treated	113.609	32
GSM325252	Patient no. 15: control	370.823	51
GSM325253	Patient no. 15: treated	363.208	51
GSM325254	Patient no. 4: control	309.023	48
GSM325255	Patient no. 4: treated	779.411	67
GSM325256	Patient no. 19: control	190.765	40
GSM325257	Patient no. 19: treated	116.768	32
GSM325258	Patient no. 14: control	182.112	35
GSM325259	Patient no. 14: treated	302.941	44
GSM325260	Patient no. 13: control	28.54	9
GSM325261	Patient no. 13: treated	28.9117	8
GSM325262	Patient no. 17: control	294.498	46
GSM325263	Patient no. 17: treated	482.973	57
GSM325264	Patient no. 10: control	313.007	49
GSM325265	Patient no. 10: treated	257.876	43
GSM325266	Patient no. 5: control	220.861	44
GSM325267	Patient no. 5: treated	191.884	46
GSM325268	Patient no. 11: control	191.322	34
GSM325269	Patient no. 11: treated	198.313	41
GSM325270	Patient no. 6: control	271.915	39
GSM325271	Patient no. 6: treated	156.859	37
GSM325272	Patient no. 8: control	414.179	54
GSM325273	Patient no. 8: treated	175.468	34
GSM325274	Patient no. 16: control	243.153	43
GSM325275	Patient no. 16: treated	44.921	16
GSM325276	Patient no. 2: control	1802.49	83
GSM325277	Patient no. 2: treated	109.632	36